PubMed

A computer simulation model of diabetes progression, quality of life, and cost.

Zhou H, Isaman DJ, Messinger S, Brown MB, Klein R, Brandle M, Herman WH.

Diabetes Care. 2005 Dec;28(12):2856-63.PMID: 16306545 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.

Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.

Pharmacoeconomics. 2004;22(15):1015-27.PMID: 15449965 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.

Brändle M, Azoulay M, Greiner RA.

Int J Clin Pharmacol Ther. 2007 Apr;45(4):203-20.PMID: 17474539 [PubMed - indexed for MEDLINE]Related articles

Model of complications of NIDDM. I. Model construction and assumptions.

Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, Manninen D, Garfield SA, Copley-Merriman C, Maier W, Eastman JF, Kotsanos J, Cowie CC, Harris M.

Diabetes Care. 1997 May;20(5):725-34.PMID: 9135934 [PubMed - indexed for MEDLINE]Related articles

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA.

Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26.PMID: 15324513 [PubMed - indexed for MEDLINE]Related articles

A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Klein R, Moss S.

Arch Intern Med. 1995 Apr 10;155(7):745-54.PMID: 7695463 [PubMed - indexed for MEDLINE]Related articles

Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life.

Wu SY, Sainfort F, Tomar RH, Tollios JL, Fryback DG, Klein R, Klein BE.

Diabetes Care. 1998 May;21(5):725-31.PMID: 9589231 [PubMed - indexed for MEDLINE]Related articlesFree article

Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model.

Tomar RH, Lee S, Wu SY, Klein R, Klein BE, Moss SE, Fryback DG, Tollios JL, Sainfort F.

J Soc Health Syst. 1998;5(4):24-37.PMID: 9785295 [PubMed - indexed for MEDLINE]Related articles

Valuing health-related quality of life in diabetes.

Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH.

Diabetes Care. 2002 Dec;25(12):2238-43.PMID: 12453967 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S.

Diabetes Care. 1994 Aug;17(8):909-17.PMID: 7956643 [PubMed - indexed for MEDLINE]Related articles

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M.

Diabetes Care. 1997 May;20(5):735-44.PMID: 9135935 [PubMed - indexed for MEDLINE]Related articles

A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).

Lee DS, Remington P, Madagame J, Blustein J.

WMJ. 2000 Jun;99(3):39-43.PMID: 10927980 [PubMed - indexed for MEDLINE]Related articles

The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.

Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A.

Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190. Review.PMID: 17927922 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Klein R, Klein BE, Moss SE, Wong TY.

Ophthalmology. 2007 Oct;114(10):1884-92. Epub 2007 May 30.PMID: 17540447 [PubMed - indexed for MEDLINE]Related articles

The direct medical cost of type 2 diabetes.

Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH.

Diabetes Care. 2003 Aug;26(8):2300-4.PMID: 12882852 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.

Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ.

Pharmacoeconomics. 2007;25(10):881-97.PMID: 17887808 [PubMed - indexed for MEDLINE]Related articles

[Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study]

Köster I, Hauner H, von Ferber L.

Dtsch Med Wochenschr. 2006 Apr 13;131(15):804-10. German. PMID: 16607599 [PubMed - indexed for MEDLINE]Related articles

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes.

Palmer AJ, Dinneen S, Gavin JR 3rd, Gray A, Herman WH, Karter AJ.

Curr Med Res Opin. 2006 May;22(5):861-72.PMID: 16709308 [PubMed - indexed for MEDLINE]Related articles